Erratum to: TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling (International Journal of Cancer, (2015), 136, 4, (955-964), 10.1002/ijc.29049);TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling

International Journal of Cancer

Volumn 136, Issue 4, 2015, Pages 955-964

  Ding, Xianfan ^a,b   Yang, Dong Rong ^b,c   Lee, Soo Ok ^b   Chen, Ya Ling ^b   Xia, Liqun ^a   Lin, Shin Jen ^b   Yu, Shicheng ^a   Niu, Yuan Jie ^d   Li, Gonghui ^a   Chang, Chawnshang ^b,e  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CCL2 CCR2; Metastasis; Prostate cancer; TR4

Indexed keywords

CELL NUCLEUS RECEPTOR; CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1; TESTICULAR NUCLEAR RECEPTOR 4; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN; CCR2 PROTEIN, HUMAN; NR2C2 PROTEIN, HUMAN; STEROID RECEPTOR; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCL2 GENE; CCR2 GENE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MALE; METASTASIS; MOUSE; NONHUMAN; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; GENETIC TRANSCRIPTION; HEK293 CELL LINE; LYMPH NODE METASTASIS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL2; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LYMPHATIC METASTASIS; MALE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RECEPTORS, CCR2; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84918815694     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.33220     Document Type: Erratum

References (32)

1. Buchanan G, Irvine RA, Coetzee GA, et al. Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 2001;20:207-23
2. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972;22:232-40
3. Chen CD, Welsbie DS, Tran C, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004;10:33-9
4. Chang C, Da Silva SL, Ideta R, et al. Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily. Proc Natl Acad Sci USA 1994;91:6040-4
5. Mu X, Lee YF, Liu NC, et al. Targeted inactivation of testicular nuclear orphan receptor 4 delays and disrupts late meiotic prophase and subsequent meiotic divisions of spermatogenesis. Mol Cell Biol 2004;24:5887-99
6. Chen YT, Collins LL, Chang SS, et al. The roles of testicular orphan nuclear receptor 4 (TR4) in cerebellar development. Cerebellum 2008;7:9-17
7. Shyr CR, Kang HY, Tsai MY, et al. Roles of testicular orphan nuclear receptors 2 and 4 in early embryonic development and embryonic stem cells. Endocrinology 2009;150:2454-62
8. Li G, Lee YF, Liu S, et al. Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a. Endocrinology 2008;149:3490-9
9. Kang HS, Okamoto K, Kim YS, et al. Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance. Diabetes 2011;60:177-88
10. Liu NC, Lin WJ, Kim E, et al. Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis. Diabetes 2007;56:2901-9
11. Izumi K, Fang LY, Mizokami A, et al. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. EMBO Mol Med 2013;5:1383-401
12. Yao JL, Ryan CK, Francis CW, et al. Tissue factor and VEGF expression in prostate carcinoma: A tissue microarray study. Cancer Invest 2009;27: 430-4
13. Ding X, Sun J, Wang L, et al. Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation. Oncol Rep 2008; 20:1041-5
14. Valdespino V, Tsagozis P, Pisa P. Current perspectives in the treatment of advanced prostate cancer. Med Oncol 2007;24:273-86
15. Akaza H. Current status and prospects of androgen depletion therapy for prostate cancer. Best Pract Res Clin Endocrinol Metab 2008;22:293-302
16. Yan SJ, Lee YF, Ting HJ, et al. Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiation. Cell Mol Biol Lett 2012;17:309-22
17. Liu S, Yan SJ, Lee YF, et al. Testicular nuclear receptor 4 (TR4) regulates UV light-induced responses via Cockayne syndrome B proteinmediated transcription-coupled DNA repair. J Biol Chem 2011;286:38103-8
18. Lin TH, Lee SO, Niu Y, et al. Differential androgen deprivation therapies with anti-Androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-Androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis. J Biol Chem 2013;288: 19359-69
19. Niu Y, Altuwaijri S, Lai KP, et al. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 2008; 105:12182-7
20. Chang C, Lee SO, Yeh S, et al. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene 2014;33:3225-34
21. Niu Y, Chang TM, Yeh S, et al. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene 2010;29:3593-604
22. Ma WL, Hsu CL, Yeh CC, et al. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology 2012;56:176-85
23. Wu MH, Ma WL, Hsu CL, et al. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med 2010; 2:32ra5
24. Ma WL, Hsu CL, Wu MH, et al. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 2008;135:947-55, 55 e1-5
25. Pienta KJ, Smith DC. Advances in prostate cancer chemotherapy: A new era begins. CA Cancer J Clin 2005;55:300-18; quiz 23-5
26. Foresti ML, Arisi GM, Katki K, et al. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpineinduced status epilepticus. J Neuroinflammation 2009;6:40
27. Roca H, Varsos Z, Pienta KJ. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem 2008;283: 25057-73
28. Loberg RD, Ying C, Craig M, et al. CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia 2007;9:556-62
29. Mizutani K, Sud S, McGregor NA, et al. The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia 2009;11:1235-42
30. Xie S, Lee YF, Kim E, et al. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation. Proc Natl Acad Sci USA 2009;106:13353-8
31. Kim E, Liu NC, Yu IC, et al. Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity. Diabetes 2011;60: 1493-503
32. Ding XF, Yu SC, Chen BD, et al. Recent advances in the study of testicular nuclear receptor 4. J Zhejiang Univ Sci B 2013;14:171-7.